0,588  0,012  Cardiovascular analeptic
0,571  0,018  5 Hydroxytryptamine release stimulant
0,559  0,014  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,538  0,037  Alzheimer's disease treatment
0,520  0,021  GABA C receptor rho-3 antagonist
0,475  0,007  Cholinergic
0,499  0,031  Cognition disorders treatment
0,458  0,005  Butyrylcholinesterase inhibitor
0,463  0,029  MAP kinase kinase 6 inhibitor
0,454  0,032  Antipsychotic
0,419  0,005  Interleukin 1 antagonist
0,421  0,013  FMO3 substrate
0,415  0,032  Metabolic disease treatment
0,391  0,020  Sedative
0,373  0,006  Topoisomerase I inhibitor
0,388  0,029  Tumour necrosis factor alpha release inhibitor
0,397  0,038  Antiepileptic
0,359  0,028  Flavin-containing monooxygenase substrate
0,335  0,011  Bipolar disorder treatment
0,352  0,029  Anticonvulsant
0,395  0,081  5 Hydroxytryptamine release inhibitor
0,362  0,053  Aldehyde oxidase inhibitor
0,319  0,011  Acetylcholinesterase inhibitor
0,387  0,080  Analgesic, non-opioid
0,357  0,059  FMO1 substrate
0,353  0,057  Anxiolytic
0,327  0,032  Cyclic AMP phosphodiesterase inhibitor
0,348  0,056  Vasodilator, coronary
0,311  0,021  Antialcoholic
0,311  0,025  Antimigraine
0,396  0,113  Caspase 9 stimulant
0,321  0,039  Interleukin agonist
0,280  0,013  DNA intercalator
0,276  0,009  Antismoking
0,307  0,040  Dependence treatment
0,309  0,046  Interleukin antagonist
0,296  0,035  Tyrosine 3 hydroxylase inhibitor
0,283  0,034  Ca2+/calmodulin-dependent kinase IV inhibitor
0,253  0,004  Antineoplastic alkaloid
0,253  0,005  5 Hydroxytryptamine 3A agonist
0,252  0,004  Transforming growth factor beta 3 antagonist
0,344  0,103  Histamine release inhibitor
0,293  0,054  Urologic disorders treatment
0,287  0,056  Antiamyloidogenic
0,274  0,045  Antiparkinsonian, rigidity relieving
0,245  0,018  5 Hydroxytryptamine 3E antagonist
0,281  0,062  GST M1-1 substrate
0,242  0,027  Acetylcholine M1 receptor antagonist
0,300  0,086  Bone diseases treatment
0,284  0,074  Antiosteoporotic
0,232  0,025  Toll-Like receptor 9 antagonist
0,219  0,012  Beta amyloid protein antagonist
0,292  0,086  CYP2D6 substrate
0,245  0,039  Urinary incontinence treatment
0,260  0,055  Psychostimulant
0,227  0,023  Alpha adrenoreceptor antagonist
0,226  0,024  Uterine stimulant
0,296  0,095  Calcium channel activator
0,332  0,131  Calcium channel L-type activator
0,245  0,045  Sleep disorders treatment
0,208  0,012  NAT2 substrate
0,212  0,015  GABA receptor agonist
0,288  0,092  Antineoplastic (small cell lung cancer)
0,209  0,014  Polo-like kinase-4 inhibitor
0,212  0,018  Endometrios treatment
0,213  0,022  GABA C receptor rho-2 antagonist
0,197  0,006  Acetylcholine M4 receptor antagonist
0,210  0,019  Antihistaminic
0,197  0,006  Alpha 1 adrenoreceptor agonist
0,219  0,030  Neuropathy treatment
0,210  0,022  Autism spectrum disorders treatment
0,205  0,017  Alpha 2 adrenoreceptor antagonist
0,220  0,031  Aldehyde oxidase substrate
0,281  0,093  Immunomodulator
0,192  0,004  5 Hydroxytryptamine 3 agonist
0,235  0,049  MAP kinase kinase 3 inhibitor
0,204  0,019  Histamine antagonist
0,185  0,005  Phosphodiesterase 3B inhibitor
0,287  0,108  Prostaglandin dehydrogenase inhibitor
0,281  0,102  Antithrombotic
0,184  0,007  5 Hydroxytryptamine 3 antagonist
0,331  0,157  Antineoplastic (solid tumors)
0,266  0,093  Respiratory analeptic
0,183  0,010  Alpha adrenoreceptor agonist
0,202  0,029  SULT1A3 substrate
0,264  0,093  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,199  0,030  5 Hydroxytryptamine 2 antagonist
0,180  0,012  GABA A receptor agonist
0,198  0,031  Toll-Like receptor antagonist
0,252  0,087  Huntington's disease treatment
0,182  0,019  Antiprotozoal (Babesia)
0,302  0,140  Analgesic
0,169  0,008  Phosphodiesterase III inhibitor
0,258  0,097  CYP2D6 inhibitor
0,161  0,003  Alpha 1L adrenoreceptor antagonist
0,175  0,019  Obsessive-compulsive disorder treatment
0,164  0,008  NMDA 2B receptor antagonist
0,172  0,018  Alpha 2a adrenoreceptor antagonist
0,182  0,028  Movement disorders treatment
0,215  0,061  Pneumotoxic
0,260  0,107  Mood disorders treatment
0,189  0,038  Phosphodiesterase inhibitor
0,169  0,017  Hedgehog signaling inhibitor
0,173  0,024  Alpha 2c adrenoreceptor antagonist
0,231  0,082  DNA synthesis inhibitor
0,242  0,093  Radiosensitizer
0,157  0,009  Dysmenorrhea treatment
0,162  0,016  Neutropenia treatment
0,235  0,089  DNA damaging
0,220  0,075  Antiulcerative
0,200  0,056  VEGF expression inhibitor
0,170  0,026  Alpha 1 adrenoreceptor antagonist
0,311  0,168  MAP kinase 1 inhibitor
0,250  0,108  Nootropic
0,168  0,027  Menstruation disorders treatment
0,233  0,093  5 Hydroxytryptamine 1E antagonist
0,169  0,032  Alpha 2b adrenoreceptor antagonist
0,307  0,170  Autoimmune disorders treatment
0,279  0,146  CYP2C19 inhibitor
0,241  0,111  Analeptic
0,170  0,042  5 Hydroxytryptamine antagonist
0,149  0,022  GABA C receptor rho-1 antagonist
0,152  0,025  Acetylcholine agonist
0,149  0,024  Alpha 1a adrenoreceptor antagonist
0,129  0,005  Cyclin-dependent kinase 6 inhibitor
0,152  0,028  5 Hydroxytryptamine 2A antagonist
0,258  0,136  GST A substrate
0,175  0,053  Hexokinase inhibitor
0,139  0,018  Potassium channel (Voltage-sensitive) activator
0,137  0,017  Interleukin 12 antagonist
0,131  0,012  Narcolepsy treatment
0,244  0,126  Interleukin 2 agonist
0,172  0,054  Antiparkinsonian, tremor relieving
0,157  0,040  Acetylcholine muscarinic antagonist
0,160  0,046  Sphingosine 1-phosphate receptor 5 antagonist
0,132  0,018  mTOR complex 1 inhibitor
0,133  0,020  Tourette's syndrome treatment
0,127  0,014  mTOR complex 2 inhibitor
0,149  0,037  Excitatory amino acid transporter EAAC1 inhibitor
0,179  0,068  Tumour necrosis factor antagonist
0,229  0,120  Hypoxia-inducible factor 1 alpha inhibitor
0,119  0,010  Antidiuretic hormone antagonist
0,222  0,114  5 Hydroxytryptamine uptake stimulant
0,123  0,015  Benzodiazepine agonist
0,158  0,050  Alpha-N-acetylglucosaminidase inhibitor
0,118  0,010  5 Hydroxytryptamine 3A antagonist
0,124  0,017  Cyclin-dependent kinase 4 inhibitor
0,130  0,023  Histamine N-methyltransferase inhibitor
0,117  0,012  Acetylcholine M5 receptor agonist
0,156  0,051  MAP kinase kinase 4 inhibitor
0,118  0,014  Sodium/hydrogen exchanger 5 inhibitor
0,239  0,136  Vasodilator, peripheral
0,140  0,036  GABA C receptor antagonist
0,109  0,007  MAP kinase kinase 7 inhibitor
0,247  0,145  Stroke treatment
0,140  0,039  Antiadrenergic
0,164  0,064  Carcinogenic, group 1
0,111  0,012  NMDA 2C receptor antagonist
0,193  0,095  HERG channel blocker
0,106  0,008  Vasopressin 1 antagonist
0,109  0,012  Alpha 2 adrenoreceptor agonist
0,122  0,026  Acetylcholine nicotinic agonist
0,159  0,063  Raynaud's phenomenon treatment
0,135  0,039  Adrenaline antagonist
0,213  0,117  Antineoplastic (bladder cancer)
0,185  0,090  Antiviral (Ebola)
0,099  0,005  Glutamate (mGluR1a) antagonist
0,181  0,086  Focal adhesion kinase 2 inhibitor
0,220  0,126  Antidepressant
0,139  0,046  5 Hydroxytryptamine 2B antagonist
0,130  0,037  Gastric antisecretory
0,136  0,044  Ferrochelatase inhibitor
0,117  0,025  NMDA 2 receptor antagonist
0,164  0,072  Neurotensin receptor agonist
0,159  0,069  Cytidine deaminase inhibitor
0,132  0,042  GABA C receptor agonist
0,097  0,007  Potassium channel small-conductance Ca-activated blocker
0,144  0,056  Cholinergic antagonist
0,142  0,054  Acetylcholine antagonist
0,115  0,027  Bromodomain-containing protein 2 inhibitor
0,126  0,039  Acetylcholine release stimulant
0,125  0,038  Protein kinase C mu inhibitor
0,119  0,033  Potassium channel activator
0,100  0,013  Protein kinase C beta inhibitor
0,179  0,094  DNA methylase inhibitor
0,207  0,121  Amyotrophic lateral sclerosis treatment
0,132  0,046  SULT1A1 substrate
0,108  0,025  Granulocyte macrophage colony stimulating factor agonist
0,113  0,030  Restless leg syndrome treatment
0,170  0,087  DNA methyltransferase I inhibitor
0,088  0,006  Dipeptidyl peptidase IV inhibitor
0,174  0,092  CYP2B6 inhibitor
0,231  0,150  CYP3A4 substrate
0,131  0,050  Cyclin-dependent kinase 1 inhibitor
0,195  0,114  Antihypotensive
0,093  0,013  Nicotinic alpha7 receptor agonist
0,091  0,011  Dipeptidyl peptidase inhibitor
0,092  0,012  Toll-Like receptor 8 antagonist
0,096  0,019  Acetylcholine M5 receptor antagonist
0,084  0,006  5 Hydroxytryptamine 3B antagonist
0,115  0,037  Acetylcholine M3 receptor agonist
0,080  0,003  Guanylate cyclase inhibitor
0,090  0,014  Histamine H3 receptor antagonist
0,118  0,042  GST T1-1 substrate
0,170  0,094  Sepsis treatment
0,191  0,117  Vascular (periferal) disease treatment
0,131  0,057  Antiprotozoal (Amoeba)
0,110  0,036  Histamine H1 receptor antagonist
0,087  0,014  Potassium channel (Ca-activated) blocker
0,103  0,030  5 Hydroxytryptamine 1F antagonist
0,143  0,071  Attention deficit/hyperactivity disorder treatment
0,091  0,019  5 Hydroxytryptamine 5A antagonist
0,085  0,013  Corticotropin releasing factor 2 receptor antagonist
0,173  0,102  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,113  0,042  Interleukin 1 beta converting enzyme inhibitor
0,079  0,009  Histamine H4 receptor antagonist
0,093  0,023  Antidote, organophosphates
0,167  0,097  Non-steroidal antiinflammatory agent
0,188  0,118  RNA-directed DNA polymerase inhibitor
0,113  0,043  Prolactin inhibitor
0,109  0,040  5 Hydroxytryptamine 2C antagonist
0,082  0,013  Phosphodiesterase 10A inhibitor
0,082  0,013  Phosphodiesterase X inhibitor
0,083  0,014  Glucosylceramidase inhibitor
0,153  0,084  UGT1A4 substrate
0,149  0,081  Hearing loss treatment
0,181  0,114  VCAM1 expression inhibitor
0,117  0,051  Vasculitis treatment
0,128  0,061  Topoisomerase II inhibitor
0,095  0,029  Vanilloid 1 antagonist
0,209  0,143  Insulysin inhibitor
0,092  0,027  Toll-Like receptor 7 antagonist
0,069  0,004  MAP3K5 inhibitor
0,098  0,034  Glycine receptor antagonist
0,094  0,030  CC chemokine 5 receptor agonist
0,139  0,076  Ca2+-transporting ATPase inhibitor
0,079  0,016  5 Hydroxytryptamine 2 agonist
0,170  0,107  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,082  0,020  5 Hydroxytryptamine 5 antagonist
0,071  0,009  Vasopressin 1A antagonist
0,160  0,098  LDLR expression enhancer
0,145  0,084  CF transmembrane conductance regulator agonist
0,103  0,043  Pim-3 kinase inhibitor
0,064  0,004  Tryptophan 5 hydroxylase inhibitor
0,181  0,121  Cytostatic
0,144  0,084  Pulmonary hypertension treatment
0,081  0,022  Acetylcholine muscarinic agonist
0,206  0,147  CYP1A2 substrate
0,079  0,021  Nicotinic neuronal receptor agonist
0,171  0,114  Potassium channel blocker
0,232  0,175  Antiobesity
0,065  0,008  Delayed rectifier potassium channel activator
0,065  0,008  Potassium channel KCNQ activator
0,087  0,030  Dopamine D1 antagonist
0,098  0,041  Tocolytic
0,064  0,007  5 Hydroxytryptamine 2B agonist
0,188  0,132  Superoxide dismutase inhibitor
0,113  0,058  Multidrug resistance-associated protein 1 inhibitor
0,138  0,083  Heat shock protein 70 antagonist
0,092  0,037  Antiviral (RSV)
0,142  0,087  Antinephritic
0,100  0,045  Antidote, mercury
0,064  0,010  Cytokine production stimulant
0,147  0,093  Muscle relaxant
0,172  0,119  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,072  0,018  Acetylcholine M1 receptor agonist
0,060  0,007  Calcitonin gene-related peptide antagonist
0,062  0,009  Acetylcholine M4 receptor agonist
0,110  0,057  MAP kinase kinase kinase inhibitor
0,109  0,056  MAP kinase 9 inhibitor
0,117  0,065  Transcription factor STAT6 inhibitor
0,062  0,010  Alpha 1d adrenoreceptor agonist
0,093  0,041  Dopamine antagonist
0,066  0,014  Alpha 1b adrenoreceptor agonist
0,133  0,082  Activin receptor-like kinase 2 inhibitor
0,061  0,011  Vasopressin 2 antagonist
0,210  0,160  CYP3A4 inhibitor
0,089  0,040  Alpha 1b adrenoreceptor antagonist
0,066  0,017  5 Hydroxytryptamine 2C agonist
0,069  0,020  Histamine agonist
0,158  0,109  Pyruvate kinase inhibitor
0,056  0,007  Complement C5a chemotactic receptor antagonist
0,083  0,035  Glycine receptor agonist
0,141  0,094  Irritable Bowel syndrome treatment
0,089  0,043  Phosphodiesterase 3A inhibitor
0,051  0,005  Alpha 1a adrenoreceptor agonist
0,080  0,035  Phospholipase D inhibitor
0,069  0,024  Prolactin release inhibitor
0,088  0,044  Cell adhesion molecule inhibitor
0,118  0,074  Contraceptive female
0,193  0,149  Transcription factor STAT inhibitor
0,197  0,154  Gastrin inhibitor
0,238  0,195  Antiparkinsonian
0,107  0,065  Protein kinase C gamma inhibitor
0,059  0,018  Glutamate (mGluR5) agonist
0,082  0,042  NAT1 substrate
0,133  0,093  Neuropeptide Y1 antagonist
0,073  0,034  Uterine relaxant
0,078  0,038  Orexin receptor 1 antagonist
0,216  0,177  Antiprotozoal (Plasmodium)
0,083  0,045  Vanilloid antagonist
0,161  0,122  Neurotrophic factor enhancer
0,135  0,096  Cyclin-dependent kinase 8 inhibitor
0,073  0,034  5 Hydroxytryptamine 2A agonist
0,225  0,187  15-Lipoxygenase inhibitor
0,085  0,048  Glutamate receptor agonist
0,063  0,026  Acetylcholine M2 receptor agonist
0,091  0,055  NADH dehydrogenase inhibitor
0,094  0,058  Protein kinase C zeta inhibitor
0,068  0,032  Glutamate (mGluR1) antagonist
0,121  0,086  Antiprotozoal (Trichomonas)
0,122  0,088  Ribosomal protein S6 kinase inhibitor
0,077  0,043  5 Hydroxytryptamine agonist
0,051  0,017  Nerve growth factor antagonist
0,081  0,049  Nicotinic alpha4beta2 receptor antagonist
0,184  0,151  CYP2C19 substrate
0,050  0,018  Histamine H1 receptor agonist
0,052  0,020  Antiviral (Enterovirus)
0,070  0,038  Antihemophilic
0,074  0,042  Dopamine D2 antagonist
0,102  0,071  DOPA decarboxylase inhibitor
0,056  0,025  Topoisomerase II beta inhibitor
0,184  0,153  UGT1A9 substrate
0,074  0,043  5 Hydroxytryptamine 1A antagonist
0,096  0,066  Nitric-oxide synthase inhibitor
0,108  0,077  Cell adhesion inhibitor
0,071  0,041  Gaucher disease treatment
0,041  0,011  ATR kinase inhibitor
0,150  0,120  I kappa B kinase epsilon inhibitor
0,187  0,157  Antihypoxic
0,062  0,033  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,075  0,047  S-adenosyl-L-methionine decarboxylase inhibitor
0,073  0,044  Transforming growth factor antagonist
0,044  0,016  Antiviral (Bovine viral diarrhea virus)
0,039  0,011  CDK4/cyclin D3 inhibitor
0,076  0,048  Histone deacetylase stimulant
0,076  0,048  Histone deacetylase SIRT1 stimulant
0,090  0,063  Glutamate release inhibitor
0,061  0,034  VEGFR2 expression inhibitor
0,054  0,027  Glutamate (mGluR group I) agonist
0,125  0,099  Skeletal muscle relaxant
0,211  0,185  Ulceration
0,045  0,019  Vascular adhesion protein 1 inhibitor
0,079  0,053  MAP kinase 10 inhibitor
0,150  0,124  Abortion inducer
0,093  0,068  Electrolyte absorption antagonist
0,059  0,033  Sphingosine kinase 2 inhibitor
0,105  0,081  Myasthenia Gravis treatment
0,140  0,116  Amyloid beta aggregation inhibitor
0,033  0,009  Follicle-stimulating hormone agonist
0,071  0,048  Bulimia treatment
0,036  0,014  Nicotinic alpha3beta4 receptor agonist
0,141  0,120  UGT2B10 substrate
0,063  0,043  Acetylcholine M2 receptor antagonist
0,126  0,106  UGT1A3 substrate
0,025  0,005  Follicle-stimulating hormone antagonist
0,037  0,018  Adenosine uptake inhibitor
0,044  0,026  Heme oxygenase inhibitor
0,080  0,062  Caspase 7 inhibitor
0,103  0,086  Caspase 3 inhibitor
0,035  0,018  Protein kinase C beta II inhibitor
0,152  0,135  Potassium channel (Voltage-sensitive) blocker
0,127  0,110  Prostatic (benign) hyperplasia treatment
0,103  0,087  Cyclin-dependent kinase inhibitor
0,023  0,007  Calcitonin gene-related peptide 1 receptor antagonist
0,180  0,164  Transcription factor STAT3 inhibitor
0,055  0,040  Immunoglobulin Fc receptor antagonist
0,072  0,057  Potassium channel (Tandem pore domain) blocker
0,178  0,164  Neuropeptide Y2 antagonist
0,066  0,052  Protein kinase B alpha inhibitor
0,044  0,031  Stearoyl-CoA desaturase inhibitor
0,068  0,055  5 Hydroxytryptamine 1 antagonist
0,070  0,058  Arylamine N-Acetyltransferase substrate
0,046  0,034  CC chemokine 4 receptor antagonist
0,056  0,044  Alpha 1d adrenoreceptor antagonist
0,062  0,049  5 Hydroxytryptamine 1B antagonist
0,117  0,105  Sphingosine 1-phosphate receptor 2 antagonist
0,161  0,149  Heart failure treatment
0,034  0,023  CDK6/cyclin D3 inhibitor
0,046  0,035  Benzodiazepine antagonist
0,020  0,009  Vesicular glutamate transport inhibitor
0,018  0,008  NMDA receptor phencyclidine site antagonist
0,055  0,045  Dopamine D4 antagonist
0,077  0,067  Inducible nitric-oxide synthase inhibitor
0,020  0,011  Histamine H4 receptor agonist
0,057  0,048  Phosphodiesterase 1A inhibitor
0,049  0,040  Aconitate hydratase inhibitor
0,145  0,136  Antirickettsial
0,062  0,053  Orexin receptor antagonist
0,052  0,043  Pim-2 kinase inhibitor
0,156  0,147  UGT1A6 substrate
0,086  0,077  Creatine kinase inhibitor
0,086  0,078  MAP kinase 8 inhibitor
0,065  0,057  Prokinetic
0,093  0,085  Cystathionine beta-synthase inhibitor
0,062  0,054  Phosphodiesterase 4B inhibitor
0,050  0,043  Nicotinic alpha3beta2 receptor antagonist
0,061  0,054  Calcium channel P-type blocker
0,054  0,047  CDK4/cyclin D inhibitor
0,110  0,103  Antianorexic
0,049  0,042  GABA A receptor antagonist
0,030  0,024  Potassium channel small-conductance Ca-activated activator
0,072  0,066  Interferon agonist
0,060  0,055  Interferon inducer
0,051  0,047  5 Hydroxytryptamine 6 antagonist
0,020  0,016  Imidazoline I1 receptor antagonist
0,176  0,172  Antiviral (West Nile virus)
0,140  0,137  Osteoarthritis treatment
0,017  0,014  Tryptophan hydroxylase 1 inhibitor
0,017  0,014  Cyclin T1 inhibitor
0,031  0,029  Protein kinase (CK2) beta inhibitor
0,048  0,047  GABA receptor antagonist
0,024  0,023  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,060  0,060  Syk tyrosine kinase inhibitor
0,159  0,158  ErbB-1 antagonist
0,026  0,026  5 Hydroxytryptamine 6 agonist
0,039  0,039  5 Hydroxytryptamine 1A agonist
0,026  0,026  Antibiotic Naphthyridine-like

